To
avoid the production of drug resistance during the antibiotic
treatment of wound infection, the use of antimicrobial peptides (AMPs)
has been strongly developed. However, its application is limited by
low bioavailability, rapid degradation of AMP, and the difficulty
of deep-tissue bacterial elimination. To solve this problem, AMP and
recombinant type III humanized collagen (Col III)-contained microneedle
patches were designed to achieve slow and controlled release of AMP
and Col III to effectively eliminate the bacteria in the deep wound
tissue and promote wound healing. AMP (KKLRLKIAFK) coupled with Cy3
was encapsulated in the nanogel (CGA-NPs), which was formed by chitosan
(CS) and gum arabic (GA) through electrostatic interactions. Microneedle
(MN) patches were dissolved after penetrating the infected skin and
biofilm formed by Staphylococcus aureus to release CGA-NPs. AMPs was released responding to the infected
microenvironment to efficiently kill bacteria, and Col III was beneficial
to promote wound healing. This is a strategy for the design and application
of a microneedle-based antimicrobial drug delivery system.